logo
What your content budget is really buying

Strivenn Thinking

Pull up a seat at our
digital campfire
where story, strategy,
and AI spark
new possibilities
for sharper brands
and smarter teams.

Marketing Strategy

What your content budget is really buying

A client told me recently that most of their business comes from word of mouth. Their marketing lead knows they need content. There is no content strategy, so assets get made piecemeal, whenever sales asks for one. Each request brings its own overhead, and little of it helps a buyer who wants to research alone.


In that business, the CEO holds the purse strings. In a larger firm, the same request lands with finance. Either way, the question back is the same. Perhaps three hundred labs in the world could buy this platform, so why fund content at all? The traffic chart shows a few hundred sessions a month, trending down.


These days more than ever, website traffic is a misleading indicator of content value. In a small scientific market, the question that matters is whether your content helps a buying decision move forward. Traffic can’t answer that. This article shows how to build a case finance can check.


Traffic answers the wrong question

Traffic is usually reported as sessions, and sessions measure how many people arrived. Sessions alone cannot show whether the right lab manager found the answer she needed, or whether your champion forwarded it to the person holding the budget. Keep traffic as a discovery diagnostic. Stop asking it to carry the business case.


Search clicks also depend on how results are presented. Pew Research Center tracked the Google searches of 900 US adults in March 2025. When an AI summary appeared, people clicked a traditional result on 8% of visits, against 15% when no summary appeared, and clicked a link inside the summary on 1% of visits. This is consumer browsing and shows an association. It still makes the point: a case built on clicks rests on a measure that moves whenever the search page changes. Search pages are now changing more than ever.


So defend the work the content does.


Your buyers decide without you

Your most important piece of content may be read when nobody from your company is in the room. A scientist is explaining a method to a colleague. A lab manager is defending a shortlist. A quality lead is asking what switching will mean. If your content helps that conversation move forward, it has done something valuable, even if the traffic chart barely moves.


The research supports the shape of this. In Gartner's 2017 survey of 750 B2B buyers, buying groups spent 17% of their purchase time meeting potential suppliers, 45% researching independently online and offline, 22% meeting each other and 16% on other activities. The survey is dated and cross-industry, so its percentages should not be treated as a description of laboratory purchasing. The useful lesson is that buying groups spend substantial time researching and discussing decisions without suppliers present.


A forwarded email from a respected colleague carries weight. In Edelman and LinkedIn's 2016 survey of 1,300 decision-makers, 84% linked the most successful thought leadership to being "forwarded by someone the recipient knows and respects". In a separate question, 56% said that most of the time they gain no valuable insight from the thought leadership they consume. Buyers pass on useful material and ignore the rest.


Indecision is the real competitor

Matt Dixon and Ted McKenna, drawing on their study of 2.5 million sales calls, put the share of deals lost to customer indecision at between 40% and 60%. The dataset is proprietary and not specific to scientific buying, so treat the range as the authors' conclusion.


In a market of a few hundred labs, the content worth paying for helps a buying group reach a decision. A method comparison that a lab manager can forward. A plain account of switching effort that finance can check. No source shows a single asset causing a single win, and you should claim none.


Content earns its budget when it helps a buying decision move forward. So bring one question to every commissioning meeting: which decision will this asset help, and how will we know whether anyone used it?


Content has five jobs

Every asset you commission should do one of five jobs:


  1. help a buyer discover you,
  2. help them understand the science,
  3. help them defend a shortlist,
  4. answer a specific objection,
  5. or be designed for circulation inside the buying group.

 

Choose one primary job per asset and commission it on that job alone. Anything else it achieves is a bonus.


Discovery still matters. Steady visibility builds on itself over time: a scientist who finds you through search today may be the one forwarding your method note next spring. In a market this small, track the relevant readers: the questions they ask, the pages they quote, the assets they pass on. Those signals tell you more than a session count.


Use, influence and incremental return

Measurement captures discovery more readily than private buying-group conversations. Some forwarding shows up in shared links, buyer interviews and CRM notes. Most of it never does. Report what you can see in three tiers.


  • Observed use comes first: named buyer questions answered, how often sales sends the asset, engagement from target accounts, and inbound questions that cite it. These signals prove the asset was used. Whether it produced an extra sale is a separate question, which the third tier addresses.

  • Influenced pipeline comes next: opportunities where a buying-group member used the asset before the deal moved. That is association, and your report should label it so.

  • Incremental return is the hard tier. Attribution rules share out credit for deals that happened. Incremental return asks what would have happened without the investment, and answering it needs a defensible counterfactual, such as a comparison group of similar accounts. Most small-market programmes cannot build one. Say so up front.


Build the case on one page

Your CEO will not accept "trust me". Write a page that survives a sceptical read before anything is commissioned:


  1. The buyer question, in the buyer's words, from call notes or interviews.
  2. Which role reads it, who they forward it to, and why they would bother.
  3. The primary job of the asset.
  4. What already exists. Update or create?
  5. The full cost: writing, scientist review, claims review, design, promotion and maintenance, including staff time.
  6. How it reaches people: who in sales sends it, which email, community or partner carries it.
  7. The leading indicators, agreed before launch.
  8. A review date and the result that means stop.

 

Make it concrete. In a hypothetical case, the buyer question is "how much revalidation will switching cost us?" The asset is a two-page application note comparing the current method with yours. Your field scientist sends it after a demo to the lab manager, who forwards it to the quality lead and the budget holder before the purchase meeting. That chain is the proposed route to value. If nobody on it would bother forwarding the note, it fails item 2 before a word is written.


Then show the break-even, with every input labelled as observed, quoted or assumed. Another hypothetical illustration, with invented figures: the note costs £5,000 in full, including staff time, reviews, promotion and a year of upkeep. Each additional sale earns £30,000 in contribution after delivery costs. At £30,000 per incremental sale, £5,000 is roughly one sixth of that value. Over twelve months, the note needs to generate at least £5,000 in expected incremental contribution to justify its cost. That is the break-even threshold. It is no estimate of the probability of success.


A note that turns up in a won deal has not proved it caused the win. Decide too whether you are judging one asset or the library it belongs to. A method comparison that sales sends every quarter supports many conversations, and repeated use shows reach. Contribution still has to be argued, and a library shares costs and overlapping effects, so judge it as one investment against the same threshold.


Sometimes the answer is no article

The same page will often tell you to commission nothing new. When I ran an AI audit on Strivenn's own site, it told me to build pages that already existed. Inventory which pages you have and identify if they are being discovered first.


Treat these as warning signs. An existing page already answers the question and needs updating. Nobody in sales can name the buyer who asked. No buying-group member would forward it, because it explains you and leaves the buyer's decision untouched. The evidence behind its claims does not exist yet. Traffic is the only success measure, and nobody can say who the reachable audience is or what they should do next.


What would justify funding?

Finance has a serious point. Money spent on content could fund a sales hire, a conference stand or a product trial instead.


Measurement research supports the caution. Randall Lewis and Justin Rao ran 25 large advertising field experiments with major US retailers and brokerages. The median confidence interval on return on investment was more than 100 percentage points wide, because individual sales swing widely relative to what advertising costs per person. In a market with only a few hundred potential buyers, precise estimates of content return may be out of reach.


That difficulty proves nothing about whether content is worth funding, and the same standard of proof would sink most conference stands too. The question is which use of the next £5,000 has the strongest credible case, given its cost, expected contribution, uncertainty and the evidence available to review it. What finance can reasonably ask for is a dated decision with stated assumptions, leading indicators and a stop rule. That falls short of proof. It gives finance something to check.


Bring the questions back

Go back to that marketing lead with the word-of-mouth business. This time they walk into the budget review with one page. Three buyer questions the sales team hears every quarter. The asset that answers each one, who forwards it, what it costs, and the date it will be reviewed. One line says an existing article gets updated and nothing new is commissioned. The requests sales used to make one at a time now have a plan behind them.


Finance can argue with that page, and so can a CEO. That is the point. You have turned a request for belief into a decision you can check together.


The longer case for keeping your buyer present in every commercial decision, including the content you fund, is in The Buyer in the Loop.

 

Are you Strivenn to Succeed?

Book your growth consultation with the marketing doctor today